Introduction
Sepsis is a major healthcare problem worldwide. It is the most common cause of admission to the intensive care unit (ICU), the leading cause of mortality in the ICU and the leading cause of mortality in children [1] . It is estimated that worldwide more than 19 million people are affected by sepsis each year.
Mortality rates range from 28% for sepsis patients to 46% in case of septic shock [1] . In 2016, the definition of sepsis was revised since previous definitions had been focusing too much on inflammation and on the Systemic Inflammatory Response Syndrome (SIRS) criteria, which appeared to be inadequately specific for sepsis. Indeed, sepsis was characterized as a systemic pro-inflammatory response, but many immunomodulatory therapies failed to show any protection in clinical trials. The new Sepsis-3 definition of 2016 describes sepsis as a life-threatening organ dysfunction resulting from a dysregulated host response to infection [2] . Furthermore, the latest septic shock definitions acknowledge the importance of metabolic changes during sepsis [3] . A large proteomic and metabolic screen on plasma of sepsis patients identified that glycolysis, gluconeogenesis and the citric acid cycle differed prominently between sepsis survivors and non-survivors [4] . Levels of lactate, an indicator of cellular and metabolic stress, can be directly correlated with disease severity, morbidity and mortality in sepsis [5] . In 2017, the World Health Organization (WHO) has recognized sepsis as a global health priority issue. Despite the fact that sepsis has been known since the times of Hippocrates and that enormous investments has been made in sepsis research, no new effective drugs have penetrated to the bedside. Today, the management of sepsis relies on antimicrobial treatment and organ supportive therapies. However, antibiotic resistance is a huge concern and this might even contribute to the increased rates of sepsis, next to the aging of the world population. Even if patients survive sepsis, many of them never fully recover, and these patients show substantial and persistent cognitive impairment and functional disability [6] . Innovative approaches targeting sepsis in combination with appropriate antibiotics are thus a huge unmet need of today's medical practice.
The structure and physiology of hypoxia-inducible factors
Hypoxia-inducible factors (HIFs) are transcription factors that are known to be the master regulators of oxygen homeostasis and are important in development, physiology and disease. They belong to the basic helix-loop-helix Per-Arnt-Sim (bHLH-PAS) transcription factor superfamily and consist of heterodimers containing an and -subunit (Figure 1) . The -subunits are known to be oxygen-sensitive, as they accumulate in hypoxic conditions. Three -subunits are found in mammals, namely HIF1, HIF2 and HIF3 [7, 8] .
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This article is protected by copyright. All rights reserved HIF1 contains a bHLH and a PAS domain, necessary for DNA binding and heterodimerization, respectively. Besides these domains, an oxygen dependent degradation domain (ODDD) as well as two transactivation domains are present: the N-terminal transactivation domain (N-TAD) and the C-terminal transactivation domain (C-TAD). The N-TAD has an overlap with the ODDD and is responsible for the stability and the target gene specificity [7, 9] . The C-TAD interacts with co-activators e.g. CREB binding protein (CBP) and p300, is required for full HIF activity and regulates the expression of most HIF target genes [10] . Finally, there are two nuclear localization signals, N-NLS and C-NLS, which direct the protein to the nucleus [11] .
HIF2 has a high structural similarity with HIF1, but they differ in their transactivation domains.
Differences in the N-TAD lead to target gene specificities of HIF1 and HIF2, whereas the C-TAD promotes the expression of their common target genes [12] . HIF3 is known as the dominant negative regulator of the HIF pathway. It shows a high structural similarity with HIF1 and HIF2 in the bHLH and PAS domains, however, the C-TAD is absent [13] . HIF3 can bind HIF1, hereby competing with HIF1 and HIF2. Also, HIF3 reduces the expression levels of HIF1 and HIF2, leading to a decreased expression of HIF1 and HIF2 target genes [14] . A splice variant of HIF3, known as the inhibitory PAS domain protein (IPAS), is able to dimerize with HIF1 and disrupt the binding of HIF1 with the hypoxia responsive elements (HREs) of its target genes [15] . This demonstrates that a negative feedback mechanism by HIF3/IPAS may be present for HIF regulation. Several animal knockout models have shown the importance of HIF1, HIF2 and HIF3 during development. HIF1 and HIF2 knockout mice are not viable. The absence of HIF1 during embryonic development leads to defects in cardiovascular development, an overwhelming degree of cell death and neural tube defects causing death at embryonic day (E)10.5 [16] . Deficiency of HIF2 causes severe abnormalities in the remodelling of the primary vascular network, leading to death in utero between E9.5 and E13.5 [17] . In contrast to HIF1 and HIF2 deficient mice, HIF3 knockout mice are viable. However, the absence of HIF3, leads to impaired heart and lung development during embryonic and neonatal stages [18] .
The constitutively expressed -subunit, also known as the aryl hydrocarbon receptor nuclear translocator (ARNT), is not affected by hypoxia [7, 8] . HIF1 also contains a bHLH domain, PAS domain and TAD domains. However, no ODDD is present, which leads to the constitutive expression of HIF1 in an oxygenindependent way [19] .
HIF protein regulation
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In oxygenated conditions, the HIF proteins are constantly produced by transcription and translation.
However, due to a half-life of 5 minutes [20] , it is directly degraded by the 26S proteasome (Figure 2) .
Under normoxic conditions, HIF proteins are post-translationally modified by prolyl hydroxylases (PHD) namely PHD1, PHD2 or PHD3. The activity of a PHD is oxygen-dependent and relies on the presence of oxygen, iron (Fe 2+ ), -ketoglutarate (-KG, also knowns as 2-oxoglutarate) and ascorbic acid (also known as vitamin C) [19] . PHD2 contributes to the regulation of HIF1, while the expression of HIF2 is regulated by PHD1 and PHD3 [21] [22] [23] . The PHDs hydroxylate proline (Pro) residues (Pro 402 and 564 for HIF1 and Pro 405 and 531 for HIF2) present in the ODDD, which leads to the binding of the von Hippel-Lindau protein (pVHL). Then, the elongin-C/elongin-B/cullin-2 E3-ubiquitin-ligase complex is recruited, targeting the HIFα protein for degradation by the 26S proteasome [24, 25] .
A second oxygen-dependent mechanism that is used for the regulation of HIFα under normoxic conditions, is based on the hydroxylation of an asparagine (Asn) residue (Asn 803 for HIF1α and Asn 851
for HIF2α) in the C-TAD by the Factor Inhibiting HIF1 (FIH). This hydroxylation prevents the interaction of the C-TAD with coactivators and inhibits the transcriptional activity of HIFα [26, 27] .
In the presence of low oxygen concentrations, or in the absence of their cofactors Fe 2+ , -KG or vitamin C, PHDs are inactivated and are unable to hydroxylate the Pro residues. The α-subunits are then stabilized, dimerize with HIF1 and translocate to the nucleus. Along with recruitment of CBP/p300 as co-factors, the heterodimer will bind to the HREs, containing an invariant core sequence RCGTG (R: A/G) [28] , for activation of their target genes [19] . Recently, Smythies et al. showed that HIF1 will bind more closely to the promotor of the target gene, while HIF2 more frequently binds enhancer, distant from the promotors [29] .
Other mechanisms of HIF protein regulation
Hypoxia associated factor (HAF) is able to regulate the HIF1α protein levels in an oxygen and pVHL independent manner. It is known to be an E3-ubiquitin ligase that will bind and ubiquitinate HIF1α
targeting it for proteasomal degradation, irrespective of the oxygen concentration [30] . Koh et al. also showed that HAF is able to bind HIF2α, at a different site than HIF1α, thereby promoting the stabilization and transactivation capacity of HIF2α [31] .
Another mechanism that can be used for the decay of HIF1α, is based on the heat-shock protein 70 (Hsp70)/carboxyl terminus of Hsp70-interacting protein (CHIP) complex. Hsp70 will bind to HIF1α, which will lead to the recruitment of CHIP, an E3-ubiquitin ligase, ubiquitination of HIF1α followed by Accepted Article proteasomal degradation. Unlike HAF, the Hsp70/CHIP complex cannot regulate HIF2α protein stability [32] .
A third manner that is used for the regulation of HIF1α protein levels is based on Hsp90 and the receptor of activated protein kinase C (RACK1). Hsp90 will protect HIF1α degradation in an O 2 independent manner by binding to the PAS domain, thereby protecting HIF1α from proteasomal degradation. However, Liu et al. showed that RACK1 can also bind to the PAS domain, hereby competing with Hsp90. Binding of RACK1 leads to the recruitment of elongin-C and elongin-B of the E3-ubiquitin ligase complex, leading to proteasomal degradation of HIF1α in a similar way of pVHL, however being O 2 independent [33] .
Posttranslational modifications
Next to hydroxylation and ubiquitination, acetylation is a third manner to induce posttranslational modifications to the HIFα proteins. Jeong et al. reported that an acetyltransferase named arrest-defective 1 (ARD1) is able to acetylate Lysine 532 (K532) present in the ODDD of HIF1α. This K532 residue is conserved in HIF1α and HIF2α, but not in HIF3α. ARD1-mediated acetylation favours the interaction of
HIF1α with pVHL and HIF1α ubiquitination, leading to proteasomal degradation [34] . However, another study by Arnesen et al. shows that ARD1 is able to bind HIF1α, but does not acetylate and destabilize the α-subunit [35] . More recently, Geng et al. observed that p300 is able to specifically acetylate K709, leading to an increased protein stability of HIF1α and decreased polyubiquitination, both in normoxia and hypoxia [36] .
Phosphorylation is also an important posttranslational modification of the HIF proteins. Under hypoxia and due to non-hypoxic stimuli, such as nitric oxide (NO) and insulin, the glycogen synthase kinase 3 (GSK3) acts directly on HIF1α by phosphorylating serine residues present in the ODDD and N-TAD. This leads to the recruitment of SCF complex (Skp1, Cul1 and F-box protein) containing the F-box protein Fbw7, a multi-subunit of E3 ubiquitin ligases, and the degradation of HIF1α [37] [38] [39] . p38, a MAPK kinase, is able to phosphorylate amino acids (AAs) in the inhibitory domain (ID), present between the N-TAD and C-TAD, and contributes to the stabilization of HIF1α [40] . Other studies have reported that phosphorylation of S641 and S643 of HIF1α by ERK1 (also known as mitogen-activated protein kinase 3, MAPK3) and ERK2 (MAPK1), downstream kinases of the MAPK pathway, favours nuclear translocation and transcriptional activity [41, 42] . ERK1 is also able to phosphorylate p300, which increases the interaction between C-TAD and p300 and thereby increasing the transactivation capacity of HIF1α proteins [43, 44] .
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Another important posttranslational modification is S-nitrosylation. Under normoxic conditions, NO is able to stabilize and transactivate HIF1α. Sumbayev et al. described that HIF1α transcriptional activity can be stimulated by activating the interaction between HIF1α and p300 due to S-nitrosylation of the cysteine 800 residue (C800) [45] . However, Cho et al. showed that S-nitrosylation of C800 leads to decreased p300
binding [46] . An overview of the posttranslational modifications regulating the protein levels and activity of the subunits can be found in Table 1 .
(Post)transcriptional regulation of HIF mRNA levels
Next to the regulation of HIF protein levels via posttranslational modifications, non-coding RNA and RNA binding proteins (RBPs) are responsible for the regulation of the translation via interaction with the 5' and 3' untranslated regions (UTRs) of HIF mRNAs [49] . The expression of HIFα mRNA and proteins can be regulated by the expression of microRNAs (miRs), also called hypoxamiRs when induced under hypoxic conditions. miRs downregulate the expression of specific target mRNAs by decreasing the expression of the transcript levels or by repressing translation [50] . During early hypoxia, miRs will induce the accumulation of HIF1α, while maintaining HIF2α and HIF3α at steady-state levels. However, during prolonged hypoxia, miRs will increase HIF2α and HIF3α while maintaining HIF1α at low levels. The expression of miR-210 is upregulated under hypoxic conditions by HIF1α and HIF2α, influencing the expression of HIF target genes [51, 52] . Two other hypoxamiRs are induced by hypoxia, namely miR-155 and miR-429. HIF1α increases the expression of miR-155 and miR-429 under hypoxic conditions. During prolonged hypoxia, these miRs will bind to the 3' UTR of HIF1α, leading to decreased levels of HIF1α mRNA levels and activity [53, 54] . Besides hypoxamiRs, also two antisense HIF1A RNA molecules (HIF1A-AS1 and HIF1A-AS2) have been identified. The expression of these molecules is upregulated after hypoxia and they are able to bind to the 3' UTR of HIF1α. This leads to the decay of the HIF1α mRNA [55, 56] .
HIF itself is able to bind HREs present in the human HIF1α-coding gene HIF1A promotor creating an autoregulatory loop in which HIF can upregulate the synthesis of HIF1A mRNA [57] . Under hypoxic Accepted Article conditions, the expression of NFB and early growth response protein 1 (Egr1) are upregulated. Binding sites for these transcription factors are present in the promotor of HIF1A, which leads to increased transcription of the HIF1A mRNA [58, 59] . To have a complete view on the experimentally found binding sites of transcription factors on the promotors of all HIFα and HIFβ coding human genes, we refer to the GeneCard tool (www.Genecards.org).
A final manner in which HIF mRNA levels and translation can be regulated, is by binding of RBPs to the 5' and/or 3' UTR of HIF transcripts [49] . RBPs like Y-box binding protein 1 (YB-1) [60] , Hu antigen R (HuR) [61] , polypyrimidine tract binding protein (PTB) [62] and cold-inducible RBP (CIRBP) [63] , are able to increase the stability of the HIF1α mRNA followed by elevated protein synthesis. On the other hand, tristetraprolin (TTP) RBP family [64] , RNA binding motif protein 38 (RBM38) [65] and cytoplasmic polyadenylation element binding proteins 1 and 2 (CPEB1 and CPEB2) [66] bind to the 3' UTR of the HIF1A mRNA leading to decreased translation. In the 5' UTR of the HIF2A mRNA, iron responsive elements (IREs) are present. Low iron concentrations induce the binding of iron regulatory proteins (IRPs) to the IREs leading to decreased HIF2α translation and protein levels [67] .
In summary, three oxygen-sensitive -subunits are known, namely HIF1, HIF2 and HIF3. In the presence of oxygen, these HIF proteins are constantly produced and post-translationally modified by PHD1, PHD2 or PHD3 leading to ubiquitination of the HIF proteins and degradation by the 26S proteasome. Another mechanism that can be used for the regulation of HIF in normoxia, is the 
Crosstalk between HIF and sepsis Inflammation induces hypoxic response
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Hypoxia and inflammation are unequivocally linked. Mountain sickness, in essence a phenomenon of systemic hypoxia, results in increased levels of circulating inflammatory cytokines and vascular leakage [68, 69] . Ischemia in organ grafts is directly linked with inflammation and transplant rejection [26] . Just as hypoxia induces inflammation, inflamed tissue can become hypoxic. Systemic spreading of pathogens during sepsis is countered by an immediate host response, characterized by intravascular coagulation and the recruitment of immune cells to the site of infection. A downside of this defense strategy is decreased tissue perfusion and edema resulting in decreased oxygen delivery to cells [70] . Furthermore, the influx of the immune cells in the inflamed tissues [71] and bacterial replication of intracellular bacteria can lead to increased oxygen consumption and cellular hypoxia [72] . Both decreased oxygen delivery and increased oxygen demand ultimately lead to tissue hypoxia during inflammation. Some cells, such as neurons and cardiomyocytes rely primarily on oxidative metabolism and are therefore very susceptible for hypoxia.
Other cell types, such as immune cells, can switch to glycolysis under hypoxic conditions and are thus tolerant for hypoxia [73] . The primary signaling pathway activated by hypoxia is the stabilization of the HIFα/HIFβ transcription factor complex.
Hypoxia triggers a paradoxical increase in reactive oxygen species (ROS) production in the mitochondria.
Low oxygen concentration reduces the mitochondrial efficiency to generate ATP, leading to proton leakage and ROS production [74] . This leads to ROS-induced PHD inhibition resulting in increased HIF1 stability and activity [75] . Possible mechanisms for this ROS-induced PHD inhibition include oxidation of -KG to succinate or ferrous iron (Fe 2+ ) to its ferric form (Fe 3+ ) thereby depleting PHD from its essential cofactors [76] . HIF1 in turn mediates the formation of alternative cytochrome c oxidase subunits improving the efficiency of electron transfer and in this way reduces ROS production under hypoxic conditions [77] . HIF drives an adaptive response to hypoxia via induction of enhanced oxygen delivery and/or decreased oxygen demand. By promoting the expression of genes that regulate erythropoiesis (EPO) and angiogenesis (VEGF), HIF increases oxygen delivery to hypoxic tissues. These processes are important in chronic hypoxic conditions, such as cancer and inflammatory bowel disease (IBD).
Short term adaptations to hypoxia are more important in acute hypoxic conditions such as inflammation.
This includes a switch from mitochondrial respiration to anaerobic glycolysis and thus reduced oxygen demand and increased glucose consumption [78] . Glycolytic genes induced by HIF1 include hexokinase (HK1), phosphofructokinase-1 (PFK1), glucose-6-Phosphate dehydrogenase (G6PD), lactate dehydrogenase (LDH), pyruvate dehydrogenase kinase (PDK1) and glutamate transporter-1 (SLC1A3) [79] .
In addition to metabolic regulation, HIF1 also directly contributes to the production of pro-inflammatory
This article is protected by copyright. All rights reserved cytokines such as IL1 [80] and regulates the expression of NOS2 mRNA [81] and phagosomal proteases, promoting bactericidal killing [82] .
Interestingly, HIF can also be activated under normoxic conditions, thus before tissues become hypoxic.
Bacteria can increase HIF1 protein expression and stimulate HIF1 transcriptional activity more than hypoxia itself [82] . A way of doing this is via limiting iron availability, an essential prerequisite for PHD enzymatic activity, by the bacterial siderophores [83] . Also host derived ferritin induced by inflammation can sequester iron and in this way activate HIF independently of oxygen availability [84] . Tannahill showed that LPS leads to HIF1 stabilization and activation via increased succinate production [80] . Succinate can be transported from mitochondria to the cytosol, where it inhibits PHD via product inhibition [84] . Just as succinate stabilizes HIF, also other metabolites, such as fumarate, pyruvate and lactate, can inhibit PHD resulting in HIF stabilization [85] . The upregulation of glycolysis by HIF1 and subsequent activation of HIF1 by glycolytic enzymes and TCA intermediates creates a positive feedback loop that drives macrophages to produce IL1 and ROS resulting in eradication of the invading pathogens [86] .
Next to the posttranslational regulation of HIF, HIF can also be regulated at transcriptional level. Under normoxic conditions, LPS can promote transcription of the HIF1 gene in monocytes and macrophages in an NFB dependent manner [87] . See point 2 for more detail.
In sepsis, it is believed that both aerobic and anaerobic glycolysis appear. After resuscitation, levels of tissue oxygen tension are preserved or even elevated in failed organs providing enough oxygen to meet the increased cellular demands [88] . Indeed, lactate production may increase even without any oxygen delivery compromise [89, 90] (Figure 3) . For example, the conversion of pyruvate to lactate requires NADH and H + . Conditions that increase the NADH/NAD + ratio, such as ketoacidosis or mitochondrial dysfunction, can thus promote lactate production independently of tissue oxygenation [90] . Next, in sepsis mitochondrial dysfunction has been reported and this in turn shifts metabolism towards glycolysis, even in the presence of oxygen. This is the so-called Warburg effect. Hypoxia can lead to mitochondrial shutdown to limit oxygen consumption as these organelles are highly oxygen consuming necessary for ATP and heat production. Oxygen independent mechanisms of mitochondrial shutdown include 1) damage to mitochondrial proteins induced by excess amounts of NO, carbon monoxide and hydrogen sulfide 2) hormonal alterations such as thyroid increase affects mitochondrial efficiency and 3) decreased transcription of mitochondrial proteins due to inflammation [78] .
The role of HIF in sepsis patients
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Recently, a clinical trial investigating HIF as a novel biomarker for septic shock has been completed (NCT02163473), but results remain to be published. Several studies have found a link between HIF and sepsis. A recent genome-wide array study with severe community-acquired pneumonia proposed two different gene expression patterns in leukocytes of subgroups of patients, termed sepsis response states SRS1 and SRS2 [91] . The SRS1 group was related to higher mortality and features of immunosuppression.
The authors identified regulatory genetic variants accounting for an upregulated expression of HIF1, HIF2 en LDHa in SRS1. This implies that genetic variations associated with the expression of genes could provide information about the immune response state and prognosis of the patient. This study creates opportunities for the development of new interventions, identification of high risk patients and ultimately individually targeted therapy [91] . Another study also identified significantly higher HIF1 mRNA expression in whole blood samples derived from septic shock patients. However, this could not be correlated with the outcome of patients. A limitation of this study was the small group of patients [92] .
Shalova et al. reported an increased expression of
HIF1α in sepsis derived monocytes, but not in monocytes derived from recovered patients [93] . In contrast, Schafer et al. showed a decrease of HIF1 mRNA and protein expression in leukocytes of sepsis patients and this was inversely associated with the severity of sepsis [94] .
Role of HIF in immunometabolism
Activation of immune cells during inflammation is associated with rapid and fundamental changes in their metabolism. Switching from oxidative phosphorylation to glycolysis provides the necessary energy and building blocks swiftly to meet their rapid division and bio-energetic demands during inflammation. In recent years there was somehow a rediscovery of metabolism by immunologists and the term immunometabolism emerged [79] . It has become clear that metabolic reprogramming in activated immune cells is not only important for their increased energetic demands but can also be directly linked to the immune cell functions. Just as in inflammation, cellular metabolism is at the crossroads of other disciplines, such as aging and cancer. Here we will discuss briefly metabolic changes that occur in innate and adaptive immunity during sepsis.
Innate immunity
The innate immune response is the first line of host defense found in all multicellular organisms. The 
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This article is protected by copyright. All rights reserved immune response is designed to a) prevent infection, b) eliminate invader pathogens, and c) stimulate the adaptive immune response. For an extensive review on the role of HIF1α in myeloid cells we refer to the recent review of Stothers et al. [86] . Here we will discuss briefly the role of HIF1 in monocyte, neutrophil and DC function.
HIF1 is found to be a regulator of monocyte functional reprogramming during sepsis. Blood monocytes from septic patients show a transition from a pro-inflammatory state to an immunosuppressive state and HIF1 is found to be the key modulator herein. Blood monocytes derived from septic patients have a higher HIF1 expression and activity as compared to recovery-monocytes. HIF1 in turn induces IRAKM, a negative regulator of the TLR signaling pathway and inducer of endotoxin tolerance, thereby driving these cells into an endotoxin-tolerant state [93] . In contrast to reducing inflammation, HIF1 is well-known to enhance inflammation by stimulating pro-inflammatory cytokine production including IL1, TNF, IL6, IL4 and IL12 expression. Conditional knock-out of HIF1 in macrophages protects against LPS-induced mortality via reducing inflammatory cytokine production [80, 95] and counteracting LPS-induced hypoglycemia [96] . Furthermore, macrophages isolated from PHD2 and HIF1 double knock out mice
show an increased oxygen consumption and a decline in lactate concentration [95] . Next to HIF1α, HIF2α also contributes to sepsis pathology. Absence of HIF2α in myeloid cells also protected against LPS-induced sepsis by a disrupted balance between pro-and anti-inflammatory cytokine production resulting in an immunosuppressive milieu [97] . Absence of PHD3 in myeloid cells leads to an enhanced pro-inflammatory response due to increased HIF1α protein stabilization and increased NFB activity [98] .
Whether HIF1 dampens or enhances inflammation could potentially be an effect of timing. Initial HIF1 activation induces a pro-inflammatory state, whereas chronic activation of this pathway during sepsis would lead to dampening of the inflammatory response [99] . In neutrophils, HIF1 promotes survival and bactericidal activity. HIF1 deletion in neutrophils is accompanied with reduced production of granule proteases, CRAMP and NO [93] and makes mice more susceptible for S. aureus infection [100] . NO in turn reciprocally regulates the stability of HIF1. HIF1 has also been shown to promote cell survival, interferon synthesis, differentiation and migration in DCs [101] . Recently, it was found that echinomycin, an inhibitor of HIF1 DNA binding and transcriptional activity, prevents the secretion of proinflammatory cytokines by DCs [102] [103] [104] .
Adaptive immunity
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This article is protected by copyright. All rights reserved The adaptive immune system is the second line of host defense and only found in vertebrates. The adaptive response is specific for the pathogen encountered. Basically, it consists of clonal expansion of T and B-lymphocytes.
HIF1 has been reported to regulate T cell survival, proliferation and differentiation. Indeed, HIF1
activation promotes a metabolic shift towards glycolysis needed for the differentiation of naïve T cells towards Th1, Th2 and Th17 cells [105] . In activated T cells, HIF1 has been reported to promote cytolytic, migratory and co-stimulatory properties. Furthermore, HIF1 activation in regulatory T cells (Tregs) via pVHL depletion leads to massive IFN production, leading to the induction of a Th1-like phenotype.
Silencing of HIF1 in Tregs restores their suppressive function [106] . HIF1 plays also a role in Th17/Treg balance via induction of RORt and targeting Foxp3 for degradation [107] . In contrast to the above- [111] and recently a critical role for HIF1 in B cells for IL10 production has been identified [112] .
HIF as a therapeutic target for sepsis
Based on the current ideas of HIF in sepsis, it would be of great interest to use HIF as a potential new therapeutic target in sepsis. Several preclinical studies have been reported where HIF has been targeted directly or indirectly.
Targeting HIF in an indirect way
The PHD inhibitor dimethyloxallyl glycine (DMOG) is able to protect against LPS-induced endotoxemia by attenuating the NFB pathway. Conversely, mice treated with DMOG could not be protected against polymicrobial sepsis, due to suppressing the inflammatory response followed by an overwhelming infection [113] . Pretreatment of mice with another PHD inhibitor, 3,4-dihydroxybenzoate (3,4-DHB), improves renal function after cecal ligation and puncture (CLP), however, the PHD inhibition leads to an
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This article is protected by copyright. All rights reserved increased mortality rate due to liver dysfunction with massive glycogen loss and apoptosis of hepatocytes [114] . Treatment with Edaravone, a potent radical scavenger, suppresses oxidative stress and protects against septic myocardial injury and dysfunction by HIF1α activation and subsequent heme oxygenase 1 induction [115] . 5,7-dihydroxy-8-methoxyflavone (DHMF) is able to protect against LPS induced acute lung injury by upregulating antioxidant enzymes. Also, pretreatment with DHMF inhibits phosphorylation of NFB and leads to an accumulation of HIF1α by increasing the hydroxylation of Pro residues by PHDs and pVHL [116] . This is in contrast with the previous study, where HIF1α activation is increased [115] .
Treatment with the statin Simvastatin, protects mice against lethal LPS injection by decreasing the hepatocellular degeneration in early phases of sepsis by reducing HIF1α levels [117] .
The impact of HIF and hypoxia on the function of immune cells identifies new potential therapeutic targets for inflammatory diseases. Currently, four PHD inhibitors are known to be in clinical use or in clinical trial for the treatment of anaemia, a commonly known complication in chronic kidney disease, namely Roxadustat [118, 119] , Vadadustat [120, 121] , Daprodustat [122] and Molidustat [123] . The development of inhibitors for specific PHD isoforms or FIH and selective HIF1 versus HIF2 inhibitors would be of great interest and would improve the therapeutic potential of interfering with the HIF pathway.
Direct targeting of HIF
An endogenous metabolite from estradiol, 2-methoxyestradiol (2-ME), prolongs survival against LPS-and CLP-induced sepsis. Pharmacological downregulation of HIF1α and its transcriptional activity by 2-ME induces a decreased cytokine and NO production in peritoneal macrophages, suggesting an important role of HIF1α expression in myeloid cells in sepsis survival [124, 125] . The HIF1α agonist L-mimosine is able to enhance the bactericidal capacities of human phagocytes due to stabilization of HIF1α. Treatment with Lmimosine leads to enhanced killing of an S. aureus infection in vitro and in vivo [126] . HIF2α specific inhibitors have been developed and show efficacy against renal cancers [127, 128] . However, the effect of these HIF2α inhibitors in immunity and inflammation is currently unknown.
Oxygen therapy in sepsis patients
Oxygen therapy is frequently administered to acutely ill patients. Oxygen supplementation is considered by many health-care providers as a harmless and potentially beneficial therapy, irrespective of the presence of hypoxia (lack of oxygen at tissue level) and hypoxemia (low blood oxygen levels). In recent years, clinical trials have been investigating the effect of liberal oxygen therapy using 100% oxygen (hyperoxia, leading to oxygen saturation levels (SpO 2 ) in the blood > 97%) compared to conservative Accepted Article oxygen therapy (80% oxygen, SpO 2 between 94% and 97%). The HYPERS2S trial (NCT01722422) showed that hyperoxia treatment for 24h in septic shock patients with a mean arterial pressure > 65 mmHg and lactate levels > 2 mmol/l despite adequate fluid resuscitation is associated with a higher mortality rate [129, 130] . In agreement with this study, Chu et al. observed a dose-dependent increased risk in shortterm and long-term mortality when patients were treated liberally with oxygen [131] . The increased mortalities observed with excessive oxygen treatment is a result of increased inflammation, oxidative stress on cardiovascular, pulmonary and neurological systems and vasoconstriction in the patient [131, 132] .
More research is required to determine the mechanisms by which liberal oxygen therapy harms acutely ill patients. Although liberal oxygen therapy increased the mortality rate, it has been proposed that liberal oxygen therapy during surgery and the immediate post-operative period reduces the risk of surgical-site infections (infections that occur after surgery in the part of the body where the surgery took place) [133] .
It would be of great interest to find a balance between the benefits of oxygen therapy on surgical-site infections and the harms of increased mortality. The Oxygen-ICU randomized control clinical trial showed that conservative oxygen therapy in critically ill patients might have a potential beneficial effect. However, a larger multicenter trial will be necessary to further evaluate the positive effects of conservative oxygenation [134, 135] . Precise control of the arterial oxygenation and the identification of biomarkers for the susceptibility to hypoxia or hyperoxia would improve further follow-up of individual patients during oxygen therapy and could be used for the modification of therapeutic strategies [131, 132] .
The role of HIF in other inflammatory diseases
Inflammatory bowel disease
IBD is a chronic intestinal inflammatory disorder resulting from a dysregulated host response in genetically predisposed people. It compromises Crohn's disease (CD) and ulcerative colitis (UC). In basal conditions, the intestinal epithelium is already in a state of physiological hypoxia due to changes in blood flow and tissue oxygenation. This hypoxic state is potentiated in IBD by increased oxygen demand and decreased blood supply [136] . It is shown that HIF1 has an important role in UC. In mice, deletion of HIF1 in the intestinal epithelial cells (IECs) leads to increased susceptibility to intestinal inflammation [137] , whereas stabilization of HIF1 by PHD inhibitors has a protective effect e.g. DMOG [138] , AKB-4924 [139] . Loss of HIF2 in the IECs protects mice against acute colitis, in contrast to HIF1 [140] .
Ischemia reperfusion
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An inadequate blood supply to an organ or other part of the body is defined as ischemia e.g. myocardial ischemia, liver ischemia. This is characterized by a reduced nutrient and oxygen supply as well as a reduced elimination of waste products of the tissue, causing irreversible tissue damage and death [141] .
Upon reperfusion, the tissue is provided again with nutrients and oxygen. However, this can cause serious tissue damage by the release of ROS, DNA and lipids. Ischemia inhibits PHDs leading to stabilization of HIF and HIF induced gene expression. Due to the release of ROS, HIF remains stabilized upon reperfusion, inducing a prolonged hypoxic phenotype [142] . Ischemic preconditioning, acute cycles of ischemia followed by reperfusion, reduces the infarct size resulting in a protecting phenotype in which HIF1 stabilization and transactivation is important. HIF1 +/mice are less protected by preconditioning in a heart ischemia reperfusion model [143] . Also, pretreatment with DMOG induces cardioprotection to the same extent as preconditioning [144] . Also in a renal ischemic model, stabilization of HIF1 and HIF2 by PHD inhibition (FG-4487) induces a protective effect [145] .
Infectious diseases
Upon infection, a hypoxic microenvironment is created which is important for the function of tissue macrophages and infiltrating neutrophils [146] . Stabilization of HIF1, by low oxygen levels or reduced PHD activity due to iron uptake by bacteria, is essential for the bacterial uptake, production of antimicrobial molecules and longevity of neutrophils. Also, the glucose metabolism of phagocytes is supported by HIF1 [69] . The absence of HIF1 in myeloid cells leads to decreased bactericidal activity of phagocytes. On the contrary, loss of VHL in myeloid cells induces an enhanced acute inflammatory response [95, 147] . The PHD inhibitor AKB-4924 mainly stabilizes HIF1 and shows the antimicrobial activity since it enhances the killing of Pseudomonas aeruginosa (Ps. aeruginosa) and Acinetobacter baumannii [148, 149] . Also, the use of DMOG inducing stabilization of HIF2 significantly attenuates pulmonary infections with Ps. aeruginosa [150] . These studies show that both HIF1 and HIF2 can be important in the killing of bacterial infections.
Organ transplantation
Solid organ transplantation e.g. liver, heart, lung is frequently followed by early graft failure. This is caused by ischemia reperfusion injury and is associated with high morbidity and mortality rates. Nowadays, there is a growing list of patients with an urgent need for transplantation and a scarcity of grafts available for transplantation, the HIF pathway can be used as a therapeutic target during transplantation [151] . Several studies indicate that HIF activators protect against acute graft failure during transplantation. PHD1
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This article is protected by copyright. All rights reserved deficient mice are protected against ischemia reperfusion injury in the liver due to increased levels of HIF2, and to lesser extent HIF1 [152] . Also, the use of DMOG as a preconditioning agent to renal ischemia reperfusion injury could be very useful in kidney transplantation [153] .
Conclusion
The studies described above highlight the interdependent relationship between inflammation and hypoxia. HIF regulation is dependent on the oxygen availability, but also on redox status, nutrient availability and certain inflammatory markers can stabilize HIF. The HIF pathway is critically involved in regulating adaptations to low oxygen levels and has also a critical role in immunometabolism. It has become clear that HIF promotes the immune functions in both innate and adaptive immunity resulting in 
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